Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.093 | 0.07 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.09 | 0.07 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.091 | 0.09 |